Skip to main content
ROCKET PHARMACEUTICALS, INC. logo

ROCKET PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · RCKT ISIN · US77313F1066 LEI · 549300R7VV82YUIN4Y93 US Manufacturing
Open in API
Filings indexed 890 across all filing types
Latest filing 2026-05-28 Merger & Acquisition
Country US United States of America
Listing US RCKT

About ROCKET PHARMACEUTICALS, INC.

https://www.rocketpharma.com/

Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company that develops gene therapies for rare and devastating diseases. The company's mission is to provide cures by correcting the root cause of disease at the genetic level. It utilizes a multi-platform approach, employing both ex vivo lentiviral (LV) and in vivo adeno-associated viral (AAV) technologies. This strategy allows for the selection of the most suitable platform for specific conditions, with a focus on diseases with high unmet needs, including bone marrow-derived and cardiovascular disorders. Rocket aims to advance a sustainable pipeline of first-in-class investigational genetic therapies for patients.

Recent filings

Filing Released Lang Actions
SC TO-I/A
Merger & Acquisition
2026-05-28 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an SEC Form 8-K current report, specifically Item 5.07 “Submission of Matters to a Vote of Security Holders.” It contains detailed vote tallies for four shareholder proposals voted on at the 2026 Annual Meeting. This is a declaration of voting results from a general meeting, matching the category for Official voting results filings.
2026-05-21 English
8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or material definitive agreements. The text describes the entry into a material definitive agreement for the sale of a Rare Pediatric Disease Priority Review Voucher (PRV) by Rocket Pharmaceuticals, Inc. It includes details about the agreement, payment terms, and regulatory conditions. There are no financial statements or detailed financial performance data included, only a description of the transaction and a reference to a future 10-Q filing for the full agreement. This type of filing is an announcement of a material definitive agreement, which fits the category of Capital/Financing Update (CAP) as it relates to a significant financing or capital transaction. The document is not an annual or quarterly report, audit report, earnings release, or any other category. Therefore, the correct classification is CAP with high confidence.
2026-04-28 English
DEF 14A - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)
Proxy Solicitation & Information Statement
2026-04-06 English
SCHEDULE 13G/A - ROCKET PHARMACEUTICALS, INC. (0001281895) (Subject)
Major Shareholding Notification
2026-03-27 English
8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The content describes a press release about FDA approval of a drug and the granting of a Rare Pediatric Disease Priority Review Voucher, along with the company's intention to evaluate strategic options to monetize the voucher. The document includes a press release as an exhibit and explicitly states that the information is not "filed" for purposes of Section 18 of the Exchange Act, indicating it is an announcement rather than a full report. The document length is 4127 characters, which is relatively short and consistent with an announcement rather than a full detailed report. There are no financial statements or detailed financial data included. This fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for filings that do not fit other specific categories.
2026-03-27 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.